← FDA Drug Approvals (Drugs@FDA)
LORAZEPAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2024-11-18
Drug application
- FDA Application #
ANDA217598- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LORAZEPAM
- Generic name
- LORAZEPAM
- Active ingredients
- LORAZEPAM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- FRESENIUS KABI USA
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2024-11-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown